Capricor Therapeutics’ investigational therapy deramiocel (CAP-1002) is being considered for approval in the U.S.

A comprehensive care approach can help people with ambulatory DMD maximize function and retain the ability to walk for as ...

An onslaught of new setbacks due to FSHD disease progression has left columnist Robin Stemple understandably anxious about ...

Columnist Betty Vertin has a day of heightened awareness about her sons' experience with wheelchairs and life with DMD.